跳至主要内容
临床试验/NCT01381484
NCT01381484已完成3 期

Efficacy and Safety of Topical Argireline in the Treatment of Periorbital Wrinkles

Mahidol University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
70
试验地点
1
主要终点
Efficacy

研究概览

简要总结

The purpose of this study is to determine whether La Jolie gel is effective in the treatment of periorbital wrinkles.

详细描述

Argireline has mechanism of action that significantly inhibited neurotransmitter release with a potency similar to that of BoNTA. Inhibition of neurotransmitter release was due to the interference of the hexapeptide with the formation and/or stability of SNARE complex. Notably, this peptide did not exhibit in vivo oral toxicity nor primary irritation at high doses. These findings demonstrate that Argireline is a anti-wrinkle peptide that emulates the action of currently used BoNTs.

In vivo study, Topical Argireline 10% is applied on lateral preorbital area twice daily for 30 days. The result demonstrates a significant anti-wrinkle activity by decreased skin wrinkle 30%. These findings demonstrate a significant anti-wrinkle activity for Argireline, in agreement with its in vitro and cellular activities. Topical Argireline represents a bio-safe alternative to BoNTs in anti-wrinkle therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • healthy woman at 35-45 years old
  • Presence of periorbital wrinkles

排除标准

  • Pregnancy
  • Keloids /scar at periorbital area
  • pre-treatment with topical periorbital products within 1 month
  • Botulinum toxin A injection,facial plastic surgery within 1 year
  • Allergic to active ingredients including acetyl hexapeptide-3 Argireline®, sodium hyaluronate,adenosine,arbutin,fucus vesiculosus)

研究组 & 干预措施

Study group

Experimental

This group received La Jolie Gel and requested to apply periorbital area and over the face for 3 months.

干预措施: 10% Argireline (Drug)

结局指标

主要结局

Efficacy

时间窗: 3 months

Objective evaluation * Noninvasive measurement by skin bioengineering technique e.g. visioscan, corneometer, cutometer * Comparative photographic evaluation by certified dermatologists Subjective evaluation * Patient Self assessment satifaction review

次要结局

  • Safety(3 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验